Officer David C. Myles files intent to sell $1.38M in Olema Pharmaceuticals stock, continuing recent sales.

summarizeSummary

An officer at Olema Pharmaceuticals has filed to sell $1.38 million in stock, adding to over $1.8 million in sales by the same individual and an associated entity in the last three months.

check_boxKey Events

• Officer Files Intent to Sell

  David C. Myles, an officer, filed a Form 144 to sell 50,000 shares of Olema Pharmaceuticals common stock.

• Significant Proposed Value

  The proposed sale is valued at approximately $1.38 million based on the current stock price.

• Pattern of Recent Dispositions

  This filing follows previous sales by Myles and an associated entity totaling over $1.8 million in the last three months.

• Acquisition via Option Exercise

  The securities to be sold were acquired through an option grant on February 1, 2023.

auto_awesomeAnalysis

David C. Myles, an officer at Olema Pharmaceuticals, has filed a Form 144 indicating an intent to sell 50,000 shares of common stock, valued at approximately $1.38 million. This proposed sale follows previous dispositions by Myles and an entity associated with him totaling over $1.8 million in the past three months. While the current proposed sale represents a small fraction of the company's market capitalization, the consistent pattern of selling by a key officer could be interpreted as a lack of conviction or a move to diversify holdings. Investors should monitor future insider activity.